stockportfolio.pro
Stocks / UTHR vs VEEV
UTHR vs VEEV
United Therapeutics Corporation and Veeva Systems Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| United Therapeutics Corporation (UTHR) | Veeva Systems Inc. (VEEV) | |
|---|---|---|
| Market cap | $23.0B | $26.3B |
| Revenue (latest FY) | $3.18B | $3.20B |
| Net income (latest FY) | $1.33B | $908.91M |
| Revenue growth (5y CAGR) | 16.5% | 16.9% |
| Net margin | 41.9% | 28.4% |
| Return on equity | 18.8% | 12.6% |
| P/E ratio | 20.0 | 28.3 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 8 | 10 |
| Positive free cash flow | Yes | — |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open UTHR — free Open VEEV — freeFrequently asked questions
Which is bigger, UTHR or VEEV?
Veeva Systems Inc. is larger by market capitalization — $26.3B versus $23.0B.
Which grows faster, UTHR or VEEV?
Over the last five fiscal years, Veeva Systems Inc. grew revenue faster — 16.9%/yr versus 16.5%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.